BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

362 related articles for article (PubMed ID: 16296803)

  • 1. Radiotargeting agents for cancer therapy.
    Kassis AI
    Expert Opin Drug Deliv; 2005 Nov; 2(6):981-91. PubMed ID: 16296803
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Radiobiologic principles in radionuclide therapy.
    Kassis AI; Adelstein SJ
    J Nucl Med; 2005 Jan; 46 Suppl 1():4S-12S. PubMed ID: 15653646
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapeutic radionuclides: biophysical and radiobiologic principles.
    Kassis AI
    Semin Nucl Med; 2008 Sep; 38(5):358-66. PubMed ID: 18662557
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relevance of radiobiological concepts in radionuclide therapy of cancer.
    Kumar C; Shetake N; Desai S; Kumar A; Samuel G; Pandey BN
    Int J Radiat Biol; 2016; 92(4):173-86. PubMed ID: 26917443
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Radiation-induced biologic bystander effect elicited in vitro by targeted radiopharmaceuticals labeled with alpha-, beta-, and auger electron-emitting radionuclides.
    Boyd M; Ross SC; Dorrens J; Fullerton NE; Tan KW; Zalutsky MR; Mairs RJ
    J Nucl Med; 2006 Jun; 47(6):1007-15. PubMed ID: 16741311
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Cancer and radiotherapy(3). Radiobiology for radiotherapy].
    Ando K
    Iyodenshi To Seitai Kogaku; 1982 Apr; 20(2):122-9. PubMed ID: 6752496
    [No Abstract]   [Full Text] [Related]  

  • 7. Requirements regarding dose rate and exposure time for killing of tumour cells in beta particle radionuclide therapy.
    Carlsson J; Eriksson V; Stenerlöw B; Lundqvist H
    Eur J Nucl Med Mol Imaging; 2006 Oct; 33(10):1185-95. PubMed ID: 16718515
    [TBL] [Abstract][Full Text] [Related]  

  • 8. From imaging to dosimetry and biological effects.
    Konijnenberg M
    Q J Nucl Med Mol Imaging; 2011 Feb; 55(1):44-56. PubMed ID: 21386784
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Radiobiological considerations of brachytherapy.
    Glicksman AS; Leith JT
    Oncology (Williston Park); 1988 Jan; 2(1):25-32. PubMed ID: 3079317
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Receptor-mediated tumor targeting with radiopeptides. Part 1. General principles and methods.
    Eberle AN; Mild G
    J Recept Signal Transduct Res; 2009; 29(1):1-37. PubMed ID: 19519167
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endoradiotherapy in cancer treatment--basic concepts and future trends.
    Zoller F; Eisenhut M; Haberkorn U; Mier W
    Eur J Pharmacol; 2009 Dec; 625(1-3):55-62. PubMed ID: 19836381
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Proceedings: Current radiobiological aspects in the therapy of tumors].
    Hug O
    Arch Klin Exp Ohren Nasen Kehlkopfheilkd; 1973 Dec; 205(2):50-4. PubMed ID: 4785540
    [No Abstract]   [Full Text] [Related]  

  • 13. Improving insight into radiobiology and radionuclide therapy.
    Goldsmith SJ
    J Nucl Med; 2004 Jul; 45(7):1104-5. PubMed ID: 15235053
    [No Abstract]   [Full Text] [Related]  

  • 14. General principles and perspectives of cancer therapy with radiopharmaceuticals.
    Shapiro B; Fig LM
    J Nucl Med Allied Sci; 1990; 34(4):260-4. PubMed ID: 2090790
    [No Abstract]   [Full Text] [Related]  

  • 15. Targeted radionuclide therapy for neuroendocrine tumours: principles and application.
    Druce MR; Lewington V; Grossman AB
    Neuroendocrinology; 2010; 91(1):1-15. PubMed ID: 19590162
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of predicted and clinical response to radiotherapy: a radiobiology modelling study.
    Hedman M; Bjork-Eriksson T; Mercke C; West C; Hesselius P; Brodin O
    Acta Oncol; 2009; 48(4):584-90. PubMed ID: 19107620
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cell kinetics.
    Wilson GD
    Clin Oncol (R Coll Radiol); 2007 Aug; 19(6):370-84. PubMed ID: 17399964
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MIRD Pamphlet No. 22 (abridged): radiobiology and dosimetry of alpha-particle emitters for targeted radionuclide therapy.
    Sgouros G; Roeske JC; McDevitt MR; Palm S; Allen BJ; Fisher DR; Brill AB; Song H; Howell RW; Akabani G; ; Bolch WE; Brill AB; Fisher DR; Howell RW; Meredith RF; Sgouros G; Wessels BW; Zanzonico PB
    J Nucl Med; 2010 Feb; 51(2):311-28. PubMed ID: 20080889
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recommendations from gynaecological (GYN) GEC ESTRO working group (II): concepts and terms in 3D image-based treatment planning in cervix cancer brachytherapy-3D dose volume parameters and aspects of 3D image-based anatomy, radiation physics, radiobiology.
    Pötter R; Haie-Meder C; Van Limbergen E; Barillot I; De Brabandere M; Dimopoulos J; Dumas I; Erickson B; Lang S; Nulens A; Petrow P; Rownd J; Kirisits C;
    Radiother Oncol; 2006 Jan; 78(1):67-77. PubMed ID: 16403584
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Biological aspects of radiation in nuclear medicine].
    Kotzerke J; Oehme L
    Nuklearmedizin; 2010; 49 Suppl 1():S5-S10. PubMed ID: 21152694
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.